Mytos

Healthtech

Mytos automates cell manufacturing for life science companies, solving the challenge of culturing human cells with precision and efficiency. Its platform enables unprecedented control over cell production processes. The company serves clients in the life sciences sector, likely across LATAM and possibly globally. It raised USD$19 million in funding, indicating significant traction in the healthtech space.